Skip to content

Effects of different concentrations of ropivacaine interscalene brachial plexus bolus block on the rebound pain after arthroscopic shoulder surgery

Effects of different concentrations of ropivacaine interscalene brachial plexus bolus block on the rebound pain after arthroscopic shoulder surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055510
Enrollment
Unknown
Registered
2022-01-11
Start date
2022-01-10
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rebound pain after nerve block

Interventions

Low concentration group:0.2% ropivacaine 20ml
High concentration group:0.5% ropivacaine 20ml

Sponsors

the Fifth People's Hospital of Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years and over, able to understand NRS pain assessment; 2. With the American Society of Anesthesiologists (ASA) physical status I–II; 3. Scheduled for elective arthroscopic shoulder surgery during study.

Exclusion criteria

Exclusion criteria: 1. Contraindications to peripheral nerve block such as local anaesthetic allergy, skin damage at puncture site or abnormal coagulation; 2. Patients with chronic pain or long-term history of taking sedative and analgesic drugs; 3. Patients with previous shoulder surgery or existing fracture, or nerve damage around shoulder joint; 4. Patients with diabetes; 5. Patients with severe liver and kidney insufficiency; 6. People with mental or neurological disorders; 7. Body weight < 35kg; 8. Reject to participate.

Design outcomes

Primary

MeasureTime frame
Incidence of pain outbreak within 24 hours after operation;

Secondary

MeasureTime frame
Rebound Pain Score;

Countries

China

Contacts

Public ContactZheng Tingting

the Fifth People's Hospital of Chengdu

1434443518@qq.com+86 18181932386

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026